Fibromuscular Dysplasia
14
7
8
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia
A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia
Florida Cerebrovascular Disease Biorepository and Genomics Center
Vascular Lab Resource (VLR) Biorepository
Defining the Basis of Fibromuscular Dysplasia (FMD)
National Registry of Rare Kidney Diseases
European/International FMD Registry and Initiative
Canadian SCAD Study
Cohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia
Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome
Pathophysiological Mechanisms of Fibromuscular Dysplasia
Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular Dysplasia
Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium